Table 1 Adverse events observed in nine patients during the canakinumab treatment period
Number (%) | |
|---|---|
Adverse events | 8 (88.9) |
Ankle fracture | 1 (11.1) |
Anxiety | 1 (11.1) |
Headache | 4 (44.4) |
Hidradenitisa | 1 (11.1) |
Pregnancy | 1 (11.1) |
Pruritus | 1 (11.1) |
Tooth infection | 1 (11.1) |
Upper respiratory tract infection | 2 (22.2) |
Vomiting | 1 (11.1) |